GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types

被引：18

作者：

Sievers, Philipp ^{[1
,2
]}

Stichel, Damian ^{[1
,2
]}

Sill, Martin ^{[3
,4
]}

Schrimpf, Daniel ^{[1
,2
]}

Sturm, Dominik ^{[3
,5
,25
]}

Selt, Florian ^{[3
,5
,6
]}

Ecker, Jonas ^{[3
,5
,6
]}

Kazdal, Daniel ^{[7
]}

Miele, Evelina ^{[8
]}

Kranendonk, Marieatte E. G. ^{[9
]}

Tops, Bastiaan B. J. ^{[9
]}

Kohlhof-Meinecke, Patricia ^{[10
]}

Beschorner, Rudi ^{[11
]}

Kramm, Christof M. ^{[12
]}

Hasselblatt, Martin ^{[13
]}

Reifenberger, Guido ^{[14
,15
]}

Capper, David ^{[16
,17
,18
,19
]}

Wesseling, Pieter ^{[9
,20
,21
]}

Stenzinger, Albrecht ^{[7
]}

Milde, Till ^{[3
,5
,6
]}

Korshunov, Andrey ^{[1
,2
,3
]}

Witt, Olaf ^{[3
,5
,6
]}

Pfister, Stefan M. ^{[3
,4
,5
]}

Wick, Wolfgang ^{[22
,23
,24
]}

von Deimling, Andreas ^{[1
,2
]}

Jones, David T. W. ^{[3
,25
]}

Sahm, Felix ^{[1
,2
,3
]}

机构：

[1] Univ Hosp Heidelberg, Inst Pathol, Dept Neuropathol, Heidelberg, Germany

[2] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany

[3] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[4] German Canc Res Ctr, German Canc Consortium DKTK, Div Pediat Neurooncol, Heidelberg, Germany

[5] Univ Hosp Heidelberg, Dept Pediat Oncol Hematol Immunol & Pulmonol, Heidelberg, Germany

[6] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Pediat Oncol, Heidelberg, Germany

[7] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany

[8] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Oncohematol & Cell & Gene Therapy, Rome, Italy

[9] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands

[10] Klinikum Stuttgart, Dept Pathol, Stuttgart, Germany

[11] Univ Tubingen, Dept Neuropathol, Tubingen, Germany

[12] Univ Med Ctr Gottingen, Div Pediat Hematol & Oncol, Gottingen, Germany

[13] Univ Hosp Munster, Inst Neuropathol, Munster, Germany

[14] Heinrich Heine Univ, Inst Neuropathol, Dusseldorf, Germany

[15] German Canc Consortium DKTK, Partner Site Essen Dusseldorf, Dusseldorf, Germany

[16] Charite Univ Med Berlin, Berlin, Germany

[17] Free Univ Berlin, Berlin, Germany

[18] Humboldt Univ, Inst Neuropathol, Berlin, Germany

[19] German Canc Res Ctr, German Canc Consortium DKTK, Partner Site Berlin, Heidelberg, Germany

[20] Amsterdam Univ Med Ctr, Locat VUmc, Dept Pathol, Amsterdam, Netherlands

[21] Brain Tumor Ctr Amsterdam, Amsterdam, Netherlands

[22] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neurooncol, Heidelberg, Germany

[23] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Dept Neurol, Heidelberg, Germany

[24] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Neurooncol Program, Heidelberg, Germany

[25] German Canc Res Ctr, Pediat Glioma Res Grp, Heidelberg, Germany

来源：

ACTA NEUROPATHOLOGICA | 2021年 / 142卷 / 06期

关键词：

CRIZOTINIB;

D O I：

10.1007/s00401-021-02369-1

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

下载

页码：1065 / 1069

页数：5

共 50 条

[11] Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma
Lim, Sun Min
Yoo, Jeong Eun
Lim, Kiat Hon
Tai, David Wai Meng
Cho, Byoung Chul
Park, Young Nyun
CANCER RESEARCH AND TREATMENT, 2017, 49 (01): : 185 - 192
[12] Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
Yoshida, Akihiko
Tsuta, Koji
Wakai, Susumu
Arai, Yasuhito
Asamura, Hisao
Shibata, Tatsuhiro
Furuta, Koh
Kohno, Takashi
Kushima, Ryoji
MODERN PATHOLOGY, 2014, 27 (05) : 711 - 720
[13] Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors
Hornick, Jason L.
Sholl, Lynette M.
Dal Cin, Paola
Childress, Merrida A.
Lovly, Christine M.
MODERN PATHOLOGY, 2015, 28 (05) : 732 - 739
[14] Analysis of ROS1 fusions in nonlung solid tumors.
Yan, Dong
Xu, Mengxiang
Wang, Weiran
Han, Yushuai
Zhu, Jianhua
Ma, Tonghui
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[15] Expression of ROS1 Predicts ROS1 Gene Rearrangement in Inflammatory Myofibroblastic Tumors
Hornick, J. L.
Sholl, L. M.
Lovly, C. M.
LABORATORY INVESTIGATION, 2014, 94 : 18A - 18A
[16] Nasopharyngeal papillary adenocarcinoma harboring a fusion of ROS1 with GOPC A case report
Wang, Jinjing
Luo, Shuai
Li, Yao
Zheng, Hong
MEDICINE, 2021, 100 (03) : E24377
[17] Expression of ROS1 Predicts ROS1 Gene Rearrangement in Inflammatory Myofibroblastic Tumors
Hornick, J. L.
Sholl, L. M.
Lovly, C. M.
MODERN PATHOLOGY, 2014, 27 : 18A - 18A
[18] ROS1 in adenocarcinomas of the lung
Carvalho, L.
Silva, M. R.
Alarcao, A.
Ferreira, T.
d'Aguiar, M. J.
Ladeirinha, A.
Sousa, V.
Reis, D.
VIRCHOWS ARCHIV, 2014, 465 : S368 - S368
[19] Lonely Driver ROS1
Savic, Spasenija
Rothschild, Sacha
Bubendorf, Lukas
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (05) : 776 - 777
[20] Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Kohno, Takashi
Nakaoku, Takashi
Tsuta, Koji
Tsuchihara, Katsuya
Matsumoto, Shingo
Yoh, Kiyotaka
Goto, Koichi
TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 156 - 164

← 1 2 3 4 5 →